Exact Sciences Corporation (EXAS) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Question-and-Answer SessionBrandon CouillardWells Fargo Securities, LLC, Research Division Never short of things to talk about when it comes to Exact. We'll get to all those things. I do want to just kind of focus on maybe to start with fundamentals in 2Q, which were kind of overshadowed by Freenome from which we'll get to, of course, Cologuard growth accelerated for the second straight quarter, you're up like 18% year-over-year. Guide implies you kind of exit the year at a high teens clip. Cologuard Plus p ...